Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KfH operates as one of Germany’s largest non-profit providers of outpatient dialysis and nephrology services, supporting patients with chronic kidney diseases and those requiring or having undergone kidney transplantation. It runs numerous specialized centers across Germany[1][2].
The organization focuses on high-quality patient care, education, and research in nephrology. No clinical trial pipeline as it does not develop drugs or devices directly.
Key principal listed as Dieter Bach[2].
Headquarters located in Neu-Isenburg, Hessen, Germany[2]. Also operates centers such as the "KfH-Nierenzentrum" in Berlin[1].
Estimated to be active since the early years of modern dialysis therapy (exact founding year not confirmed from search results).
No evidence of being acquired or merged.
No public trading symbol; operates as a non-profit association.
Focuses exclusively on healthcare delivery rather than pharmaceutical/biotech R&D.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KfH Kuratorium für Dialyse und Nierentransplantation.